in this issue
Markets :: Specialty Chemicals :: Electronic chemicals
H.C. Starck Financial Performance Surges in 2011, Owners Mull Sale or IPO
1:29 PM MDT | April 3, 2012 | Sotirios Frantzanas
H.C. Starck's Ebitda increased 90% for full year 2011, to €190 million ($253 million ), according to figures published by Reuters citing sources close to H.C. Starck. H.C. Starck has not commented on the leaked Ebitda figures. The company has published sales figures showing that its 2011 sales increased 28% to €883.2 million compared with €689.3 million in 2010. The owners of the company, private equity groups Advent and Carlyle, are seeking to sell the group or to launch an IPO, sources told Reuters. The owners of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee